Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Director/PDMR Shareholding

12 Jan 2026 17:30

RNS Number : 5855O
Volex PLC
12 January 2026
 

LEI: 213800HBLQNH5FXXGE63

12 January 2026

Volex plc

("Volex" or "the Company")

Director / PDMR Dealing

Volex plc (AIM:VLX) announces that on Thursday 8 January 2026, Sir Peter Westmacott received 31 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") at the reference price of 399.0 pence per share, through the scrip dividend issued on Thursday 8 January 2026, as set out in the notification of dealing form below.

 

Following this issue, Sir Peter Westmacott holds 7,890 Ordinary Shares, representing 0.004% of the ordinary issued share capital of the Company.

 

The below notification made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

 

1

Details of the Director / person discharging managerial responsibilities / person closely associated 

a)

Name

 Peter Westmacott

 

2

Reason for the notification

a)

Position/status

Senior Non-Executive Director

b)

Initial notification / Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

Name

Volex plc

b)

LEI

213800HBLQNH5FXXGE63

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument 

Ordinary Shares of 25 pence each

Identification code 

GB0009390070

b)

Nature of the transaction

Scrip dividend issue

c)

Price(s) and volume(s) 

31 Ordinary Shares of 25 pence each at a price of 399.0 pence per Ordinary Share.

d)

Aggregated information

- Aggregated volume

See 4(c) above.

- Aggregated price

e)

Date of the transaction

8 January 2026

f)

Place of the transaction 

Outside a trading venue

 

 

 For further information please contact:

 

Volex plc

Lord Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

Chris Bedford, Group General Counsel and Company Secretary

 

+44 (0) 1256 442570 investor.relations@volex.com

 

Peel Hunt LLP - Nominated Adviser & Joint Broker

Ed AllsoppDom ConveyTom Graham

 

+44 (0)20 7418 8900

Jefferies - Joint Broker

Philip NobletSam BarnettHarry Le May

+44 (0)207 029 8000

 

Sodali & Co - Media Enquiries

James White

Nicholas Johnson

+44 (0)20 7250 1446

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDLLFFQFLFBBD
Date   Source Headline
13th Jun 20112:26 pmRNSPreference Share Dividend
7th Jun 20112:14 pmRNSVolex announces dividend and record payment dates
1st Jun 20117:00 amRNSPreliminary Results
14th Apr 20117:00 amRNSTrading Update
17th Feb 20114:10 pmRNSDirector/PDMR Shareholding
16th Feb 20111:33 pmRNSInvestor Seminar
16th Feb 20117:00 amRNSInterim Management Statement
6th Jan 20117:00 amRNSAppointment of Non - Executive Director
13th Dec 201012:07 pmRNSNotification of Major Interest in Shares
8th Dec 20107:00 amRNSRelease of Special Reserve
7th Dec 20107:00 amRNSNew Ordinary Shares issued
22nd Nov 201012:22 pmRNSNotification of Major Interest in Shares
22nd Nov 20107:00 amRNSVoting Rights and Capital
2nd Nov 20107:00 amRNSHalf-yearly results
5th Oct 20107:00 amRNSNew Share Issuance
1st Oct 20103:15 pmRNSResult of GM
23rd Sep 20107:00 amRNSAppointment
16th Sep 20107:00 amRNSNotice of General Meeting
25th Aug 20102:10 pmRNSDirector PDMR Shareholding
2nd Aug 20107:00 amRNSAnnual Information Update
27th Jul 20107:00 amRNSInterim Management Statement
26th Jul 20102:02 pmRNSSpecial Resolutions Passed at AGM
14th Jul 201011:53 amRNSResult of AGM
5th Jul 201011:19 amRNSRule 9.6.14
25th Jun 20104:49 pmRNSNotification of Major Interest in Shares
21st Jun 20109:49 amRNSNotification Of Major Interest In Shares
17th Jun 201010:52 amRNSAnnual Report and Accounts & Notice of AGM
10th Jun 20104:29 pmRNSNotification Of Major Interests In Shares
1st Jun 20107:00 amRNSPreliminary Results
19th May 20101:36 pmRNSBlock Listing Six Monthly Return
19th May 20101:35 pmRNSBlock Listing Six Monthly Return
26th Apr 201010:35 amRNSNotification Of Major Interest In Shares
19th Apr 20107:00 amRNSTrading Update
7th Apr 201010:00 amRNSAppointment of joint broker
29th Mar 20109:40 amRNSDirector/PDMR Shareholding
22nd Mar 20104:38 pmRNSHolding(s) in Company
18th Mar 20101:00 pmRNSPartnership with Huawei
3rd Mar 201012:13 pmRNSHolding(s) in Company
9th Feb 20107:00 amRNSInterim Management Statement
1st Feb 201012:00 pmRNSAward Win
25th Jan 20103:00 pmRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Statement
11th Jan 201012:10 pmRNSHolding(s) in Company
5th Jan 20107:00 amRNSAward Win
29th Dec 200912:08 pmRNSHolding(s) in Company
18th Dec 20097:00 amRNSCompletion of management changes
18th Nov 20091:51 pmRNSChange of Registered Office
3rd Nov 20097:00 amRNSHalf Yearly Report
28th Oct 20092:42 pmRNSHolding(s) in Company
28th Oct 20092:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.